IQVIA's investments in these technologies could yield significant returns. The company's ability to integrate AI across its service offerings has the potential to enhance the efficiency and ...

IQVIA conducted a thorough ... Integrating the patient journey Failures in patient engagement and retention can delay or stop a clinical trial. DCT studies are proving to be helpful with this ...

and accelerate R&D efforts that are for patients and driven by them. Stewart Rosen, MD, vice president, medical, clinical trial educators, IQVIA Bringing more than 35 years of industry experience ...

President of Integrated Health Services at IQVIA (formerly Quintiles), and Principal of the Life Sciences Commercial practice at Deloitte Consulting. Additionally, he sits on the Board of Worldwide ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

IQVIA: BIOSIMILAR VOID AWAITS — A new report from health data firm IQVIA released Monday found that of the 118 biologics with expiring patient ... green light to a clinical trial examining ...

This database includes 10 million patient records and 20 million high-resolution slide images. Such a comprehensive ... Human digital twins can be used in clinical trials, medical training ...

This trial was conducted ... especially beneficial for patients with swallowing difficulties, including the elderly, stroke survivors, and children. According to IQVIA, the global market for ...